Evotaz (Atazanavir / Cobicistat)

Evotaz has two active ingredients: atazanavir 300 mg and cobicistat 150 mg. Atazanavir blocks a critical protein in HIV viral particles and prevents it from replicating. Cobicistat "boosts" the amount of atazanavir in the bloodstream by slowing its metabolism.

Evotaz can cause the redistribution of fat tissue. Tell your healthcare provider if you experience this symptom. Use caution if you have a history of kidney or liver problems. Use caution if you have a history of bleeding disorders ordiabetes.

Tell your doctor and pharmacist if you experience any of the following Evotaz side effects: Abnormal dreams, Decreased neutrophils, Depression, Diarrhea, Dyslipidemia, Fanconi syndrome, Fatigue, Glycosuria, Headache, Hematuria, Increased bilirubin, Increased creatinine phosphokinase, Increased gamma-glutamyl transferase, Increased serum glucose, Insomnia, Jaundice, Nausea, Renal disease, Skin rash, Upper abdominal pain, Vomiting Dr. Sheehy (BSc Molecular Biology, PharmD) works a clinical pharmacist specializing in cardiology, oncology, and ambulatory care. He’s a board-certified pharmacotherapy specialist (BCPS), and his experience working one-on-one with patients to fine tune their medication and therapy plans for optimal results makes him a valuable subject matter expert for our pharmacy.Read More....